Making sense of e-detailing in Japan’s pharmaceutical sector
RT @claudiobini: Making sense of e-detailing in Japan’s pharmaceutical sector http://t.co/bRGCSbS4...
Reactions
(6)
Pharma Marketing Blog: U.S. e-Detailing Spending Up 74% in 2012. Yet Pharma Still NOT "Digitally Mature."
"#Pharma Still NOT "Digitally Mature." http://t.co/dafpAoOC4n
eMedToday's curator insight,
August 5, 2013 11:08 PM
Pharma spend about 4 time as digitally mature industries
Not good
Key Marketing Metrics mHealth Brands Should Track
Do you know how your website visitors find your website? Do you know what they do once they are there and what information they like the best?
eMedToday's curator insight,
August 5, 2013 10:48 PM
This is great index of metrics hospital should track.
However, most do not
New Pharma approach: from (e-)detailing to customer & patients
In the demand for a new business model for pharma, the roadmap from current promotion via detailing to a more engaging way to physicians and health care provide
mHealth Monitoring Offers 36bn USD Global Healthcare Cost-savings Opportunity by 2018: The Raise of mhealth Smartphone
Hampshire, 17th July 2013. ---Cardiac and chronic disease remote patient monitoring to result in less time in hospital and fewer outpatient visits ---...
eMedToday's curator insight,
July 29, 2013 8:12 PM
"Juniper Research’s latest report on the mHealth market forecasts cumulative cost savings from remote patient monitoring of up to 36 billion USD globally over the next five years - under Juniper’s most optimistic forecast scenario"
eMedToday's curator insight,
July 26, 2013 7:40 PM
Doctors are using the internet to search for information.
Trend data shows that mean weekly usages before, during and after a patient consult have all increased year-over-year, suggesting that online medical resources are increasingly being incorporated into physicians’ daily work flow.
You can make the case for developing an e detailing platform for doctor which include a valualble clinical resource like a great resources called up to date
eDetailing: The future for pharma communication?
Dinesh Chindarkar, Co-founder, MediaMedic Communications elucidates about eDetailing – where technology and graphics, married with rich content, come to the rescue of mundane communication. Detailing has always been the backbone of doctors’ communication with the pharma industry for over the last three to four decades. This print tool, though has undergone quality improvements in terms of its content, visual appeal, some added gimmicks etc; all these have been value-adds within the box. Nothing has challenged it so far.
With the advent of technology, video content, graphics, motion and interactivity, and newer digital tools are challenging this visual aid and redefining communication. This version of detailing adds an ‘e’ of electronic to it, making it completely different from the current mode of communication. A different form of eDetailing is one where communication is sent to doctors on the PC without a personal interaction. But we are talking of eDetailing in the context where the electronic detailing aid is used by the sales rep in person-to-person call.
The objective of having a rich, content – driven conversation with the doctor, so as to discuss about newer medical advances, sharing updated information and help him make the right decision for prescription can be achieved using eDetailing. All this can be done weaving the brand within the conversation rather than the brand dominating the communication.
eMedToday's curator insight,
July 26, 2013 8:12 PM
This does reflect the changing trend.
However, problem is getting in front of the doctor.
Self directed e detialing it the future
kiey
Today, the majority of all physician e-details taking place globally are happening in Japan. Part of this is because Japan is the world’s second-largest pharmaceutical market in terms of sales; the country also has an advanced digital infrastructure. The number of smart phones and tablets both owned and used by physicians—and not just the younger ones—has also grown markedly in recent years. Moreover, external pressures such as stricter rules (i.e., a ban on excessive entertainment from sales reps and restrictions on hospital visits) and changing customer dynamics have prompted pharma companies to experiment with new approaches. Specifically, they are using a combination of their own Internet websites and emerging physician portals, such as MedPeer, Carenet or m3.com.